آخر تحديث :
15/10/2021
الاستقرار والتوافق للادويه عن
نرحب بك في Stabilis. إذا كنت ترغب في الحصول على النشرة الإخبارية الفصلية،اكتب عنوان بريدك الإلكتروني هنا سجل

إذا كان لديك أي أسئلة أو تعليقات، الرجاء الاتصال ب: infostab@stabilis.org
قاعدة البيانات  
مراجع : 2660
مركبات : 817
الفئة الدوائية : 46
استقرار المحلول : 5939
الاستقرار في مخاليط : 1187
التوافق : 11956
الإسم التجاري : 4525
أخبار - مركبات  
أدوية تخدير عام عن طريق الفم  Ketamine 15/10/2021
مكافحة عدم اتساق نبضات القلب عن طريق الفم  Propafenone Hydrochloride 31/08/2021
هرمون كيس ورقي Melatonine 31/08/2021
المضادة للسرطان المخدرات حقن Lurbinectedin 27/08/2021
مسكن عن طريق الفم  Buprenorphine 16/07/2021
موسع الشرايين عن طريق الفم  Ambrisentan 16/07/2021
المضادة للسرطان المخدرات حقن Gemtuzumab ozogamicin 03/06/2021
هرمون المراهم Estrone 03/06/2021
هرمون المراهم Progestérone 03/06/2021
هرمون المراهم Testostérone 03/06/2021
المضادة للسرطان المخدرات حقن Pemetrexed diarginine 03/06/2021
هرمون المراهم Estradiol 01/06/2021
أدويه مخفضه للضغط عن طريق الفم  Nicardipine hydrochloride 26/05/2021
  مضاد للتخثر حقن Nafamostat 19/04/2021
هرمون حقن Thiamazole 09/03/2021
مزيل القلق كبسولة Midazolam hydrochloride 03/03/2021
مختلف حقن Turoctocog alfa 03/03/2021
مضاد حيوي حقن Cefiderocol sulfate tosylate 03/03/2021
مكافحة عدم اتساق نبضات القلب حقن Flecainide acetate 04/12/2020
مضاد حيوي حقن Cefotiam 04/12/2020
أخبار - مراجع  
تاريخ الادخال
4608 Durvalumab (Imfinzi - Summery of Product Characteristics, updated August 2021) Astra Zeneca 19/08/2021
4606 Study on the Optimal Conditions for Long-term Storage of Melatonin Powder as an In-hospital Preparation. Int J Pharm Compound 10/08/2021
4605 Impact of physical incompatibility on drug mass flow rates: example of furosemide-midazolam incompatibility. Ann Allergy 09/08/2021
4602 Physical and Chemical Stability of Dexamethasone Sodium Phosphate in Intravenous Admixtures Used to Prevent Chemotherapy-Induced Nausea and Vomiting. Hosp Pharm 06/08/2021
4603 Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration. Hosp Pharm 06/08/2021
4600 Physicochemical stability of lurbinectedin reconstituted at 500 µg/mL and diluted at 15, 30, and 70 µg/mL in 0.9% sodium chloride and 5% dextrose. EJOP 04/08/2021
4589 Pemetrexed Mylan - Résumé des caractéristiques du produit Mylan 18/06/2021
4587 Stability-indicating LC-MS Method for Determination of Stability of Extemporaneously Compounded Buprenorphine Oral Syringes for Neonatal Abstinence Syndrome. J Pediatr Pharmacol Ther 09/06/2021
4584 Long-term stability of 10 mg/mL dobutamine injectable solutions in 5% dextrose and normal saline solution stored in polypropylene syringes and cyclic-oleofin- copolymer vials. EJHP 26/05/2021
4583 Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags Int J Pharm Compound 25/05/2021
4578 Etude de stabilité de médicaments anticancéreux injectables : apports analytiques et pharmaceutiques 12/05/2021
4579 Application of the HPLC Method in Parenteral Nutrition Assessment: Stability Studies of Ondansetron Processes 12/05/2021
4575 Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt. Int J Pharm Compound 06/05/2021
4576 Stability of Extemporaneously-compounded Nadolol 10-mg/mL Suspension in Oral Mix in Glass and Plastic Bottles and Plastic Syringes. Int J Pharm Compound 06/05/2021
4577 Stability of Fagron's Phytobase Cream Compounded with Various Hormones. Int J Pharm Compound 06/05/2021
4572 Toward Safe Pharmacotherapy: The Interplay between Meropenem and Parenteral Nutrition Admixtures. Antibiotics 04/05/2021
4571 Levosimendan (Simdax 2.5 mg/ml) - Summary of Product Characteristics Orion Pharma 19/04/2021
4568 Long-term physico-chemical stability of 5-fluorouracile at standardised rounded doses (SRD) in MyFuser® portable infusion pump. Journal of Chemotherapy 13/04/2021
4569 Y-Site Compatibility of Intravenous Levetiracetam With Commonly Used Critical Care Medications. Hosp Pharm 13/04/2021
4570 Investigations of Physical Compatibilities of Commonly Used Intravenous Medications with and without Parenteral Nutrition in Pediatric Cardiovascular Intensive Care Unit Patients. Pharmaceuticals 13/04/2021
4567 Addition of Regular Insulin to Ternary Parenteral Nutrition: A Stability Study. Pharmaceutics 08/04/2021
4560 Stability Determination of an Extemporaneously Compounded Ambrisentan Suspension by High Performance Liquid Chromatography Analysis. J Pediatr Pharmacol Ther 07/04/2021
4561 New liquid oral formulations of hydroxychloroquine: a physicochemical stability study. Pharmaceutical Technology in Hospital Pharmacy 07/04/2021
4563 Stability study of a compounded oral solution of nicardipine for the treatment of hypertension in children. Eur J Pharm Sci 07/04/2021
4556 The Physical Compatibility of Clinically Used Concentrations of Diltiazem Hydrochloride With Heparin Sodium. J Pharm Technol 24/03/2021
4558 Compatibility of Hydroxyethyl Starch and Tranexamic Acid for Battlefield Co-Administration. Milit Med 24/03/2021
4559 Physical Compatibility and Chemical Stability of Fentanyl and Naloxone Hydrochloride in 0.9% Sodium Chloride Injection Solution for Patient-Controlled Analgesia Administration. Drug Design Dev Ther 24/03/2021
4546 Stability of pemetrexed diarginine concentrates for solution in vials and diluted in 0.9% sodium chloride and dextrose 5% polyolefin infusion bags. EJHP 23/03/2021
4547 Formulation and stability of an extemporaneously compounded propafenone hydrochloride oral suspension for children with arrhythmia. EJHP 23/03/2021
4548 Intravenous Compatibility of Ceftazidime/Avibactam and Aztreonam Using Simulated and Actual Y-site Administration. Clin Ther 23/03/2021

  Mentions Légales